Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

businessinsider.com - Madeline Berg - The GLP-1 gold rush is creating winners far beyond pharma
The GLP-1 gold rush is creating winners far beyond pharma
Business Insider

Every month, sales executive Kelly Freeman spends about $112 on Ozempic, which he started taking in 2024 for diabetes. The drug is one line item in a long list of GLP-related costs. There are supplements, an Apple watch, a life coach, a functional…

cnbc.com - Elsa Ohlen - Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
CNBC

Once the go-to location for global drugmakers, Europe is losing market share to aggressive U.S. trade policies and China's growth as a biotech hub. Europe's share of global R&D has been cut in half over the past 35 years, with more companies…

bloomberg.com - Stock Movers: Lumentum, Sun Pharma, Porsche
Stock Movers: Lumentum, Sun Pharma, Porsche
Bloomberg

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for…

seekingalpha.com - Dulan Lokuwithana - Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)
Organon rises as Sun Pharma nears buyout deal (OGN:NYSE)
Seeking Alpha

Organon (OGN) shares continued to climb on Friday, adding ~11% in the premarket after media reports from India indicated that Mumbai-based generic drugmaker Sun Pharmaceutical Industries had submitted a $12B binding offer for the U.S. company.

news-medical.net - Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
News-Medical

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements, Insilico Medicine…

scroll.in - Chinmay Tumbe  - 'Made in India': A fine exposition of the personal and professional in creating pharma brand Lupin
'Made in India': A fine exposition of the personal and professional in creating pharma brand Lupin
Scroll.in

Is there any major Indian industry without the dominance of the Tatas, Birlas, Ambanis, and other large legacy business houses? Think of IT and automobiles, and you run into TCS and Tata Motors. If it is finance, you have the Bajajs. Take any of…

thehindu.com - The Hindu Bureau - Raichur-based pharma firm wins two State safety awards
Raichur-based pharma firm wins two State safety awards
The Hindu

Raichur-based Shilpa Pharma Lifesciences Ltd. won two awards at the Karnataka State Level Safety Awards presentation during the National Safety Day celebrations at the NIMHANS Convention Centre in Bengaluru on Thursday. The event was organised by…

thehindubusinessline.com - Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
Sun Pharma shares down 4 per cent on reports of overtures for US-based Organon
BusinessLine

Sun Pharmaceutical Industries' shares closed down almost 4 percent at ₹1,654.70 on BSE, following reports that the drugmaker was close to sealing a deal for US-based Organon, in a $12 billion deal, its biggest transaction yet. Known to be…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
Urogen Pharma (NASDAQ:URGN) Shares Gap Up - Time to Buy?
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) shares gapped up prior to trading on Friday. The stock had previously closed at $20.53, but opened at $21.40. Urogen Pharma shares last traded at $20.9650, with a volume of 93,817 shares changing hands.

marketbeat.com - OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of 'Hold' by Brokerages
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of 'Hold' by Brokerages
MarketBeat

Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have been given an average rating of 'Hold' by the five analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one…

qz.com - Cris Tolomia - Eli Lilly loses weight loss drug market share as generics flood India
Eli Lilly loses weight loss drug market share as generics flood India
Quartz

March data tracked by industry intelligence provider Pharmarack show a five-percentage-point slide in Eli Lilly $LLY 's slice of India's GLP-1 weight-loss market, dropping from 61% to 56% as a wave of cheap semaglutide generics arrived following…

swissinfo.ch - swissinfo.ch - World skiing championship for toddlers held in Switzerland
World skiing championship for toddlers held in Switzerland
www.swissinfo.ch

The programme for these young skiers includes training sessions, followed by three age-appropriate competitions in giant slalom, combined slalom and parallel slalom. A ranking will be drawn up after each race, followed by an overall ranking to…

fool.com - Motley Fool Transcribing - Simulations Plus (SLP) Q2 2026 Earnings Transcript
Simulations Plus (SLP) Q2 2026 Earnings Transcript
The Motley Fool

Thursday, April 9, 2026 at 5 p.m. ET Chief Executive Officer — Shawn O'Connor Chief Financial Officer — William Frederick Need a quote from a Motley Fool analyst? Email [email protected] Total Revenue -- $24.3 million, up 8% with both…

cnbc.com - Davis Giangiulio - Stocks making the biggest moves midday: Palantir, Marvell, CoreWeave, Zscaler & more
Stocks making the biggest moves midday: Palantir, Marvell, CoreWeave, Zscaler & more
CNBC

Here are the names making headlines in midday trading. Chip stocks – Big chip plays surged as investors snapped up semiconductor companies instead of software. Marvell jumped nearly 7% and headed for a third consecutive positive session.

seekingalpha.com - Albert Anthony - Equinix: An Investment-Grade Data Center REIT With A Compelling Growth Story (NASDAQ:EQIX)
Equinix: An Investment-Grade Data Center REIT With A Compelling Growth Story (NASDAQ:EQIX)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

Receive a Daily briefing on Pharma Industry News

Get Started